Neurocognitive Impairment in Patients Treated with Protease Inhibitor Monotherapy or Triple Drug Antiretroviral Therapy

BACKGROUND: In patients who remain virologically suppressed in plasma with triple-drug ART a switch to protease inhibitor monotherapy maintains high rates of suppression; however it is unknown if protease inhibitor monotherapy is associated to a higher rate of neurocognitive impairment. METHODS: In...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Pérez-Valero, Ignacio, González-Baeza, Alicia, Estébanez, Miriam, Montes-Ramírez, María L., Bayón, Carmen, Pulido, Federico, Bernardino, José I., Zamora, Francisco X., Monge, Susana, Gaya, Francisco, Lagarde, María, Rubio, Rafael, Hernando, Asunción, Arnalich, Francisco, Arribas, José R.
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2013
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3723908/
https://ncbi.nlm.nih.gov/pubmed/23936029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0069493
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars